FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer
Journal of Translational Medicine · 02.01.2025 · 23 (1)
DOI: 10.1186/s12967-024-06014-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Translational Medicine, online erschienen am 02.01.2025. Verfasst von Gang Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, No.71, Xinmin Street, Changchun City, Jilin Province, P…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Proto-Oncogene Proteins c-fos, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Youth Foundation of China, Natural Science Foundation of Jilin Provincial Department of Science and Technology.
Abstract (Originalsprache)
BACKGROUND: Dysregulated energy metabolism has emerged as a defining hallmark of cancer, particularly evident in triple-negative breast cancer (TNBC). Distinct from other breast cancer subtypes, TNBC exhibits heightened glycolysis and aggressiveness. However, the transcriptional mechanisms of aerobic glycolysis in TNBC remains poorly understood. METHODS: The Cancer Genome Atlas (TCGA) cohort was utilized to identify genes associated with glycolysis. The role of FOSL1 in glycolysis and tumor growth in TNBC cells was confirmed through both loss-of-function and gain-of-function experiments. The subcutaneous xenograft model was established to evaluate the therapeutic potential of targeting FOSL1 in TNBC. Additionally, chromatin immunoprecipitation and luciferase reporter assays were employed to investigate the transcriptional regulation of glycolytic genes mediated by FOSL1. RESULTS: FOSL1 is identified as a pivotal glycolysis-related transcription factor in TNBC. Functional verification shows that FOSL1 enhances the glycolytic metabolism of TNBC cells, as evidenced by glucose uptake, lactate production, and extracellular acidification rates. Notably, FOSL1 promotes tumor growth in TNBC in a glycolysis-dependent manner, as inhibiting glycolysis with 2-Deoxy-D-glucose markedly diminishes the oncogenic effects of FOSL1 in TNBC. Mechanistically, FOSL1 transcriptionally activates the expression of genes such as SLC2A1, ENO1, and LDHA, which further accelerate the glycolytic flux. Moreover, FOSL1 is highly expressed in doxorubicin (DOX)-resistant TNBC cells and clinical samples from cases of progressive disease following neoadjuvant chemotherapy. Targeting FOSL1 proves effective in overcoming chemoresistance in DOX-resistant MDA-MB-231 cells. CONCLUSION: In summary, FOSL1 establishes a robust link between aerobic glycolysis and carcinogenesis, positioning it as a promising therapeutic target, especially in the context of TNBC chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, No.71, Xinmin Street, Changchun City, Jilin Province, P.R. China.
- Anhui University of Science and Technology Affiliated Fengxian Hospital, Shanghai, China.
- Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, No.71, Xinmin Street, Changchun City, Jilin Province, P.R. China. jdyydy@jlu.edu.cn.
ORCID-Profile: Ye Du
Förderung
- National Natural Science Youth Foundation of China
- Natural Science Foundation of Jilin Provincial Department of Science and Technology
Zitieren
APA
Zhao, G., Liu, Y., Yin, S., Cao, R., Zhao, Q., Fu, Y., & Du, Y. (2025). FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer. Journal of Translational Medicine, 23(1). https://doi.org/10.1186/s12967-024-06014-9
Vancouver
Zhao G, Liu Y, Yin S, Cao R, Zhao Q, Fu Y, et al. FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer. Journal of Translational Medicine. 2025;23(1). doi:10.1186/s12967-024-06014-9
BibTeX
@article{Zhao2025,
author = {Zhao, Gang and Liu, Yutong and Yin, Shiqi and Cao, Runxiang and Zhao, Qian and Fu, Yifan and Du, Ye},
title = {FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer},
journal = {Journal of Translational Medicine},
year = {2025},
volume = {23},
number = {1},
doi = {10.1186/s12967-024-06014-9}
}
EUVIMED